Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022
Wed, March 30, 2022
Tue, March 29, 2022
Mon, March 28, 2022

Emmanuel Papadakis Maintained (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-200-on-apr-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $217 on, Tuesday, February 1st, 2022


This is the rating of the analyst that currently disagrees with Emmanuel


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $339 on, Wednesday, February 23rd, 2022

Publication Contributing Sources